anmelden
FTSE All-Share
5.832,63
PKT
+38,13
PKT
+0,66
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu FTSE All-Share-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 13.02.23 | Glencore Overweight | JP Morgan Chase & Co. | |
| 13.02.23 | BAT Overweight | JP Morgan Chase & Co. | |
| 13.02.23 | Unilever Buy | Jefferies & Company Inc. | |
| 13.02.23 | National Grid Outperform | RBC Capital Markets | |
| 10.02.23 | BAT Outperform | Credit Suisse Group | |
| 10.02.23 | Unilever Outperform | Credit Suisse Group | |
| 10.02.23 | AstraZeneca Neutral | UBS AG | |
| 10.02.23 | Unilever Sell | UBS AG | |
| 10.02.23 | Unilever Buy | Deutsche Bank AG | |
| 10.02.23 | BAT Buy | Deutsche Bank AG | |
| 10.02.23 | AstraZeneca Buy | Deutsche Bank AG | |
| 10.02.23 | BAT Sector Perform | RBC Capital Markets | |
| 10.02.23 | Unilever Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 10.02.23 | GSK Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 10.02.23 | AstraZeneca Neutral | Credit Suisse Group | |
| 10.02.23 | Glencore Neutral | UBS AG | |
| 10.02.23 | Unilever Underweight | JP Morgan Chase & Co. | |
| 10.02.23 | Unilever Neutral | Goldman Sachs Group Inc. | |
| 09.02.23 | Unilever Sector Perform | RBC Capital Markets | |
| 09.02.23 | BAT Neutral | Goldman Sachs Group Inc. | |
| 09.02.23 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 09.02.23 | Unilever Neutral | Goldman Sachs Group Inc. | |
| 09.02.23 | Unilever Underperform | Bernstein Research | |
| 09.02.23 | Unilever Sell | UBS AG | |
| 09.02.23 | BAT Overweight | JP Morgan Chase & Co. | |
| 09.02.23 | Unilever Sector Perform | RBC Capital Markets | |
| 09.02.23 | AstraZeneca Hold | Jefferies & Company Inc. | |
| 09.02.23 | Unilever Buy | Jefferies & Company Inc. | |
| 09.02.23 | Unilever Underweight | JP Morgan Chase & Co. | |
| 09.02.23 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 08.02.23 | BP Overweight | Barclays Capital | |
| 08.02.23 | BP Hold | Jefferies & Company Inc. | |
| 08.02.23 | BP Conviction Buy List | Goldman Sachs Group Inc. | |
| 08.02.23 | Glencore Outperform | RBC Capital Markets | |
| 08.02.23 | BP Outperform | RBC Capital Markets | |
| 07.02.23 | Diageo Underperform | RBC Capital Markets | |
| 07.02.23 | BP Buy | UBS AG | |
| 07.02.23 | BP Conviction Buy List | Goldman Sachs Group Inc. | |
| 07.02.23 | BP Hold | Jefferies & Company Inc. | |
| 07.02.23 | AstraZeneca Buy | Deutsche Bank AG |
